- Home
- WRBY vs ACAD Comparison
WRBY vs ACAD Comparison
Compare WRBY & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- ACAD
- Stock Information
- Founded
- WRBY 2010
- ACAD 1993
- Country
- WRBY United States
- ACAD United States
- Employees
- WRBY N/A
- ACAD N/A
- Industry
- WRBY Ophthalmic Goods
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- WRBY Health Care
- ACAD Health Care
- Exchange
- WRBY Nasdaq
- ACAD Nasdaq
- Market Cap
- WRBY 3.1B
- ACAD 3.4B
- IPO Year
- WRBY 2021
- ACAD 2004
- Fundamental
- Price
- WRBY $24.07
- ACAD $19.95
- Analyst Decision
- WRBY Buy
- ACAD Buy
- Analyst Count
- WRBY 12
- ACAD 19
- Target Price
- WRBY $22.25
- ACAD $25.33
- AVG Volume (30 Days)
- WRBY 1.2M
- ACAD 1.6M
- Earning Date
- WRBY 02-27-2025
- ACAD 02-26-2025
- Dividend Yield
- WRBY N/A
- ACAD N/A
- EPS Growth
- WRBY N/A
- ACAD N/A
- EPS
- WRBY N/A
- ACAD 0.78
- Revenue
- WRBY $742,527,000.00
- ACAD $929,236,000.00
- Revenue This Year
- WRBY $16.92
- ACAD $36.88
- Revenue Next Year
- WRBY $13.42
- ACAD $8.01
- P/E Ratio
- WRBY N/A
- ACAD $25.70
- Revenue Growth
- WRBY 13.47
- ACAD 47.06
- 52 Week Low
- WRBY $11.35
- ACAD $14.15
- 52 Week High
- WRBY $28.68
- ACAD $26.56
- Technical
- Relative Strength Index (RSI)
- WRBY 38.22
- ACAD 60.25
- Support Level
- WRBY $24.64
- ACAD $19.52
- Resistance Level
- WRBY $26.08
- ACAD $20.29
- Average True Range (ATR)
- WRBY 1.13
- ACAD 0.68
- MACD
- WRBY -0.32
- ACAD 0.08
- Stochastic Oscillator
- WRBY 9.72
- ACAD 72.62
About WRBY Warby Parker Inc.
Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.